Roberts I
Department of Biochemistry, University of Surrey, Guildford, UK.
Hum Reprod. 1988 Aug;3(6):815-7. doi: 10.1093/oxfordjournals.humrep.a136789.
The development of medical means of inducing abortion requires a detailed knowledge of the abortion legislation. It is vital that these compounds are developed and used within the legal constraints of the country involved. In the United Kingdom, despite the Act of Union (1707), England and Scotland have not united under one legal system. In England the common law on abortion was superseded by the Offences Against the Persons Act (1861) which declared abortion illegal. This Act does not apply to Scotland where, up until 1967, common law applied. The Abortion Act of 1967 is an exemption act allowing abortion, under certain restrictions, to be legally performed. Whilst post-coital contraception is not covered by any of the abortion legislation, it is clear that contragestion and medical abortion is restricted by the current abortion legislation, hence medication will need to be taken in hospital.
诱导堕胎医疗手段的发展需要详细了解堕胎立法。至关重要的是,这些化合物要在相关国家的法律限制范围内研发和使用。在英国,尽管有《联合法案》(1707年),但英格兰和苏格兰并未统一于一个法律体系之下。在英格兰,堕胎的普通法被《侵犯人身罪法》(1861年)取代,该法案宣布堕胎为非法行为。该法案不适用于苏格兰,在1967年之前,苏格兰适用普通法。1967年的《堕胎法》是一项豁免法案,允许在某些限制条件下合法进行堕胎。虽然性交后避孕不在任何堕胎立法范围内,但很明显,抗孕和药物流产受到现行堕胎立法的限制,因此药物需要在医院服用。